To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.
DRAVP ID DRAVPa2469
Peptide Name Sequence 5 from Patent CN117659140A
Sequence FLWLLWPVT
Sequence Length 9
Source Synthetic construct
Target Organism SARS-CoV-2
Patent Type Patent Application
Publication Date 2024-03-08
Patent No CN117659140A
Family Info CN 117659140 A
Patent Title New coronavirus HLA-A2 restrictive epitope peptide and application thereof
Comment
Abstract The invention provides a novel coronavirus HLA-A2 restrictive epitope peptide and application thereof. Specifically, the invention provides a separated polypeptide, the amino acid sequence of the separated polypeptide is FLWLLWPVT (SEQ ID NO: 5), and the separated polypeptide is a novel coronavirus SARS-CoV-2HLA-A2 restrictive epitope polypeptide. Also provided herein are complexes comprising the polypeptides, articles of manufacture, and uses thereof. The related active substances and products can be used for detection, diagnosis, prevention and/or treatment of SARS-CoV-2 related diseases.
To the extent possible under law, the person who associated CC0 with this work has waived all copyright and related or neighboring rights to this work.